Medtronic Plc Stock Performance
| MDT Stock | USD 91.14 0.73 0.79% |
On a scale of 0 to 100, Medtronic PLC holds a performance score of 11. The company secures a Beta (Market Risk) of 0.0868, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Medtronic PLC's returns are expected to increase less than the market. However, during the bear market, the loss of holding Medtronic PLC is expected to be smaller as well. Please check Medtronic PLC's jensen alpha, skewness, relative strength index, as well as the relationship between the value at risk and day median price , to make a quick decision on whether Medtronic PLC's current price movements will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Medtronic PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak fundamental indicators, Medtronic PLC unveiled solid returns over the last few months and may actually be approaching a breakup point. ...more
| Medtronic PLC dividend paid on 10th of January 2025 | 01/10/2025 |
| Begin Period Cash Flow | 1.5 B |
Medtronic |
Medtronic PLC Relative Risk vs. Return Landscape
If you would invest 8,033 in Medtronic PLC on December 20, 2024 and sell it today you would earn a total of 1,154 from holding Medtronic PLC or generate 14.37% return on investment over 90 days. Medtronic PLC is generating 0.2363% of daily returns assuming volatility of 1.5735% on return distribution over 90 days investment horizon. In other words, 14% of stocks are less volatile than Medtronic, and above 96% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Medtronic PLC Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtronic PLC's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtronic PLC, and traders can use it to determine the average amount a Medtronic PLC's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1502
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | MDT | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.57 actual daily | 14 86% of assets are more volatile |
Expected Return
| 0.24 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.15 actual daily | 11 89% of assets perform better |
Based on monthly moving average Medtronic PLC is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtronic PLC by adding it to a well-diversified portfolio.
Medtronic PLC Fundamentals Growth
Medtronic Stock prices reflect investors' perceptions of the future prospects and financial health of Medtronic PLC, and Medtronic PLC fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtronic Stock performance.
| Return On Equity | 0.0844 | ||||
| Return On Asset | 0.0466 | ||||
| Profit Margin | 0.13 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 136.95 B | ||||
| Shares Outstanding | 1.28 B | ||||
| Price To Earning | 20.44 X | ||||
| Price To Book | 2.39 X | ||||
| Price To Sales | 3.56 X | ||||
| Revenue | 32.36 B | ||||
| EBITDA | 8.2 B | ||||
| Cash And Equivalents | 1.54 B | ||||
| Cash Per Share | 8.59 X | ||||
| Total Debt | 26.05 B | ||||
| Debt To Equity | 0.51 % | ||||
| Book Value Per Share | 38.48 X | ||||
| Cash Flow From Operations | 6.79 B | ||||
| Earnings Per Share | 3.28 X | ||||
| Total Asset | 89.98 B | ||||
| Retained Earnings | 30.4 B | ||||
| Current Asset | 23.6 B | ||||
| Current Liabilities | 7.17 B | ||||
About Medtronic PLC Performance
Assessing Medtronic PLC's fundamental ratios provides investors with valuable insights into Medtronic PLC's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medtronic PLC is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 95000 people.Things to note about Medtronic PLC performance evaluation
Checking the ongoing alerts about Medtronic PLC for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtronic PLC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 86.0% of the company shares are owned by institutional investors |
- Analyzing Medtronic PLC's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtronic PLC's stock is overvalued or undervalued compared to its peers.
- Examining Medtronic PLC's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtronic PLC's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtronic PLC's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtronic PLC's stock. These opinions can provide insight into Medtronic PLC's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Medtronic Stock Analysis
When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.